The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
Source: https://www.cnbc.com/2024/05/10/novavax ... shots.html
Novavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shots
